COVID-19 immunoglobulin G antibodies in healthy blood donors paving way to herd immunity

COVID-19 immunoglobulin G antibodies in healthy blood donors paving way to herd immunity

Blog Article

Background and Objectives: ucsb gaucho blue Herd immunity is the immunity or resistance to particular infection that occurs in group of people when a very high percentage of individuals have been vaccinated or previously exposed to infection.The goal of this study was to assess the development of herd immunity to COVID-19 in parts of Western India.Methods: The study was conducted at a tertiary care hospital in India on routine blood donors who were tested for SARS-CoV-2 immunoglobulin G (IgG) antibody.We systematically investigated 808 healthy donors at various points of time in the 3-month period starting from September 2020 to November 2020 for SARS-CoV-2 seroprevalence.Results: The results of November month show a sudden increase (51.

96%) in the later half.The seroprevalence in healthy donors in other towns and cities shows an aggregate average of SARS-CoV-2 IgG antibody 13.59% (200/1472) as against Jaipur city with 36.12% (292/808).Deedwana has orange zinger tomato higher seropositivity in blood donors 31.

5% (24/76) whereas Sujangarh and Jhunjhunu did not have any donors with seropositive status.Conclusion: Our findings could be the tip of iceberg of emerging herd immunity to SARS-CoV-2 infection in India.Future research will determine how long these antibodies will last.Will they be protective toward future COVID-19 infection?.